Bent Pfaffenrot

Design and synthesis of 1H-pyrazolo[3,4-b]pyridines targeting mitogen-activated protein kinase kinase 4 (MKK4) - A promising target for liver regeneration.

L. Zender, S. Laufer, W. Albrecht, 2021, European journal of medicinal chemistry.

Scaffold modified Vemurafenib analogues as highly selective mitogen activated protein kinase kinase 4 (MKK4) inhibitors.

L. Zender, Stefan A. Laufer, W. Albrecht, 2022, European journal of medicinal chemistry.

From off-to on-target: New BRAF-inhibitor-template-derived compounds selectively targeting mitogen activated protein kinase kinase 4 (MKK4).

L. Zender, S. Laufer, W. Albrecht, 2020, European journal of medicinal chemistry.

Design and synthesis of novel fluorescently labeled analogs of vemurafenib targeting MKK4.

S. Laufer, W. Albrecht, Tatu Pantsar, 2020, European journal of medicinal chemistry.